These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 28562582)
41. Activation-induced deaminase expression defines mature B cell lymphoma in the mouse. Gómez-Escolar C; Marina-Zárate E; Ramiro AR Front Immunol; 2023; 14():1268930. PubMed ID: 37809061 [TBL] [Abstract][Full Text] [Related]
42. Improved access to CD20 following B cell receptor cross-linking at Burkitt's lymphoma cell surfaces. Holder MJ; Chamba A; Hardie DL; Deans JP; Gordon J Leuk Res; 2004 Nov; 28(11):1197-202. PubMed ID: 15380345 [TBL] [Abstract][Full Text] [Related]
43. [Activation of protooncogenes by point mutations in hematological malignancies]. Goto T; Nishimura J Nihon Rinsho; 1992 Jun; 50(6):1335-40. PubMed ID: 1518154 [TBL] [Abstract][Full Text] [Related]
44. The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas. Refaeli Y; Young RM; Turner BC; Duda J; Field KA; Bishop JM PLoS Biol; 2008 Jun; 6(6):e152. PubMed ID: 18578569 [TBL] [Abstract][Full Text] [Related]
45. c-MYC impairs immunogenicity of human B cells. Schlee M; Schuhmacher M; Hölzel M; Laux G; Bornkamm GW Adv Cancer Res; 2007; 97():167-88. PubMed ID: 17419945 [TBL] [Abstract][Full Text] [Related]
46. B-cell receptor signaling in chronic lymphocytic leukemia and other B-cell malignancies. Koehrer S; Burger JA Clin Adv Hematol Oncol; 2016 Jan; 14(1):55-65. PubMed ID: 27057669 [TBL] [Abstract][Full Text] [Related]
48. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells. Barnouin K; Fredersdorf S; Eddaoudi A; Mittnacht S; Pan LX; Du MQ; Lu X Oncogene; 1999 Nov; 18(46):6388-97. PubMed ID: 10597239 [TBL] [Abstract][Full Text] [Related]
49. MicroRNA-17~92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways. Jin HY; Oda H; Lai M; Skalsky RL; Bethel K; Shepherd J; Kang SG; Liu WH; Sabouri-Ghomi M; Cullen BR; Rajewsky K; Xiao C EMBO J; 2013 Aug; 32(17):2377-91. PubMed ID: 23921550 [TBL] [Abstract][Full Text] [Related]
50. Altered gene expression upon BCR cross-linking in Burkitt's lymphoma B cell line. Nakayama Y; Iwamoto Y; Maher SE; Tanaka Y; Bothwell AL Biochem Biophys Res Commun; 2000 Oct; 277(1):124-7. PubMed ID: 11027651 [TBL] [Abstract][Full Text] [Related]
51. Quantitative modeling of signaling in aggressive B cell lymphoma unveils conserved core network. Klinger B; Rausch I; Sieber A; Kutz H; Kruse V; Kirchner M; Mertins P; Kieser A; Blüthgen N; Kube D PLoS Comput Biol; 2024 Oct; 20(10):e1012488. PubMed ID: 39352924 [TBL] [Abstract][Full Text] [Related]
52. Ras activation of Erk restores impaired tonic BCR signaling and rescues immature B cell differentiation. Rowland SL; DePersis CL; Torres RM; Pelanda R J Exp Med; 2010 Mar; 207(3):607-21. PubMed ID: 20176802 [TBL] [Abstract][Full Text] [Related]
53. Differential organization of tonic and chronic B cell antigen receptors in the plasma membrane. Gomes de Castro MA; Wildhagen H; Sograte-Idrissi S; Hitzing C; Binder M; Trepel M; Engels N; Opazo F Nat Commun; 2019 Feb; 10(1):820. PubMed ID: 30778055 [TBL] [Abstract][Full Text] [Related]
54. HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling. Walter R; Pan KT; Doebele C; Comoglio F; Tomska K; Bohnenberger H; Young RM; Jacobs L; Keller U; Bönig H; Engelke M; Rosenwald A; Urlaub H; Staudt LM; Serve H; Zenz T; Oellerich T Blood; 2017 Feb; 129(5):598-608. PubMed ID: 28064214 [TBL] [Abstract][Full Text] [Related]
55. The transcriptional program of a human B cell line in response to Myc. Schuhmacher M; Kohlhuber F; Hölzel M; Kaiser C; Burtscher H; Jarsch M; Bornkamm GW; Laux G; Polack A; Weidle UH; Eick D Nucleic Acids Res; 2001 Jan; 29(2):397-406. PubMed ID: 11139609 [TBL] [Abstract][Full Text] [Related]
57. Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells. Irish JM; Czerwinski DK; Nolan GP; Levy R Blood; 2006 Nov; 108(9):3135-42. PubMed ID: 16835385 [TBL] [Abstract][Full Text] [Related]
58. GCN5 HAT inhibition reduces human Burkitt lymphoma cell survival through reduction of MYC target gene expression and impeding BCR signaling pathways. Farria AT; Mustachio LM; Akdemir ZHC; Dent SYR Oncotarget; 2019 Oct; 10(56):5847-5858. PubMed ID: 31645904 [TBL] [Abstract][Full Text] [Related]
59. Inclusion of a sensitivity control to add a quality-control parameter and improve reproducibility in BCR, immunoglobulin, and T-cell receptor gene-rearrangement studies. Devlin BH; Ratech H; Kaufman R Diagn Mol Pathol; 1994 Dec; 3(4):271-4. PubMed ID: 7866638 [TBL] [Abstract][Full Text] [Related]
60. SH2 domain-containing inositol 5-phosphatases support the survival of Burkitt lymphoma cells by promoting energy metabolism. Mayr F; Kruse V; Fuhrmann DC; Wolf S; Löber J; Alsouri S; Paglilla N; Lee K; Chapuy B; Brüne B; Zenz T; Häupl B; Oellerich T; Engelke M Haematologica; 2024 May; 109(5):1445-1459. PubMed ID: 37916396 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]